Lakshmi Rajdev

Medical Oncology Director, Mount Sinai Morningside, NYC. GI Medical oncologist and researcher. Science, travel, fashion, humor.....and so much more!

[Manish A Shah @MDmanishshah]

Tune in to the episode wherever you listen to podcasts.

Apple Podcasts - https://t.co/8uEOnNA3Qu
Spotify - https://t.co/v4pHbQ7si7
YouTube - https://t.co/Nl9upvief6
Weill Cornell Medicine website – https://t.co/8MkdwF4W6L

[Suneel Kamath MD @SKamath_MD]

Can AI actually foster more empathy in doctor-patient communication?

Join me, @kimberly_kuk and @dougfloramd for a panel discussion on how AI is transforming the doctor-patient dialogue in cancer care!

Scan the QR to register.

[Manish A Shah @MDmanishshah]

Take a BITE out of cancer! Dr @mmejia91 recently came on the @WeillCornell #CancerCast podcast to discuss how bispecific t-cell engager, or BiTE, therapy works to target #cancer, common side effects & how this treatment differs from other #immunotherapy https://t.co/YrKcActc8R

[Mount Sinai Tisch Cancer Center @TischCancer]

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update | Journal of Clinical Oncology https://t.co/iOGAqIoLcl
Lakshmi Rajdev, MD, MS, and colleagues
@luckydoc2 @IcahnMountSinai

[Manish A Shah @MDmanishshah]

Checkout #CancerCast - a cancer oriented Podcast on new therapies in cancer! #Oncology @OncoAlert

I spoke with #Melanoma expert Dr. Barbara Ma about the “nuts & bolts” of this new form of cellular immunotherapy & what the future holds for other cancers https://t.co/2AA4FhVEp1

[MSK Department of Medicine @MSK_DeptOfMed]

Happening next at #ESMO25: @YJanjigianMD will lead a session on how she and other experts are identifying new treatments to improve outcomes for those with gastroesophageal adenocarcinoma. @MSKCancerCenter @myESMO

Learn more: https://t.co/uAmKdFHSbV

[Sharlene Gill, MD, MPH, MBA, FASCO @GillSharlene]

#ESMO25
Don’t forget to check out the @myESMO booth (Hall 4.2) & take a selfie at the photo booth! 📸
#50years
#myESMOstory
#ESMOAmbassadors

[Midhun Malla @MallaMidhun]

GPC3 directed Radioligand Therapy in HCC: Honored to present Trials in Progress Poster @ESMO_Open @ONealCancerUAB. Great to run into good friend and collaborator, @HardingJJMD #esmo2025
Enrollment is ongoing!!

[Lorenza Rimassa @LorenzaRimassa]

CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC
#ESMO25 #ESMOAmbassadors
@myESMO

[Dr. Cathy Eng @CathyEngMD]

🙏@ChiaraCrem1 @esmo #ESMO25 for reminding providers that IO therapy in #TMBhigh in MSS #colorectal #cancer provides NO benefit despite agnostic FDA approval. Yamaguchi et al, ESMO open, 2025. I have been reiterating this repeatedly, so IMP to use regular chemo in this setting. #CancerResearch @myESMO

[Sunnie Kim, MD @SunnieSKim]

Impressive mOS signal in the Phase 2 study, will see if it remains in the Phase 3 STAR 221 study.

[Yelena Y. Janjigian MD @YJanjigianMD]

From OGs 🧬 to next-gen therapies 🚀 Honored to sit down with the pioneers who shaped HER2 as a target. Our new CME activity with @touchONCOLOGY is now live:
👉 https://t.co/cqiM02v7Tk @MSKCancerCenter

[Dr Amol Akhade @SuyogCancer]

Hi ALL
Did one new experiment on oncology social media 🙂
Made my account on Substack and uploaded my article on it 👇
If you find it useful, DO share or subscribe and comment 🙂.
https://t.co/vdGEf10Vb6

[ECOG-ACRIN Cancer Research Group @eaonc]

Read more from our co-chairs on the importance of protecting public support for biomedical research: https://t.co/iZjvYy1cKX #CancerResearch #ClinicalTrials

[Yelena Y. Janjigian MD @YJanjigianMD]

That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn @MSKCancerCenter

[Lakshmi Rajdev @luckydoc2]

@GillSharlene @ASCO @CDNCancerTrials @GICancer @howiel2013 @oncology_bg Clearly plenary-worthy!!

[Lakshmi Rajdev @luckydoc2]

@YJanjigianMD @ASCO @taylorswift13 @MSKCancerCenter @MarcelaMaus @KlempnerSam @StomachCancer_ @oncodaily Goodluck

[Dr. Cathy Eng @CathyEngMD]

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https://t.co/a3Ih35lp3Y

Glad to see this finally come out from the @theNCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer

[AKHIL CHAWLA @MDAkhilChawla]

🗞️📄Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group | JCO Precision Oncology https://t.co/W0KtMU9Fxs
@aparna1024 @FlavioRochaMD @SyedAAhmad5 @NMSurgery

[Erman Akkus @Erman_Akkus]

🧬ctDNA in clinical trials of GI cancers:
Position paper of NCI GI Onc WG
@JCOPO_ASCO

➡️Prospective trials are required
➡️Group supports
✅ctDNA as a primary efficacy end point for phase II studies
✅as a noninvasive evaluation strategy for new drug development

👉https://t.co/HP9u207eWL

@ASCO @JCOOP_ASCO @JCOGO_ASCO @OncoAlert @realbowtiedoc #cancer #oncology #MedX